Here is the latest financial fact sheet of AAREY DRUGS. For more details, see the AAREY DRUGS quarterly results and AAREY DRUGS share price.
1 Day | % | -3.3 |
No. of shares | m | 25.38 |
1 Week | % | -5.4 |
1 Month | % | -15.4 |
1 Year | % | -35.6 |
52 week H/L | Rs | 56.0/28.5 |
No. of Mths Year Ending |
12 Mar-18* |
12 Mar-19* |
12 Mar-20* |
12 Mar-21* |
12 Mar-22* |
5-Yr Chart Click to enlarge
|
---|
AAREY DRUGS EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | 144 | 64 | 30 | 42 | 64 | |
Low | Rs | 44 | 26 | 12 | 13 | 22 | |
Sales per share (Unadj.) | Rs | 148.8 | 151.7 | 128.4 | 149.0 | 194.1 | |
Earnings per share (Unadj.) | Rs | 2.6 | 2.8 | 2.5 | 2.8 | 2.6 | |
Diluted earnings per share | Rs | 2.4 | 2.6 | 2.3 | 2.6 | 2.6 | |
Cash flow per share (Unadj.) | Rs | 2.9 | 3.2 | 2.9 | 3.2 | 3.4 | |
Dividends per share (Unadj.) | Rs | 0 | 0.10 | 0 | 0 | 0 | |
Adj. dividends per share | Rs | 0.00 | 0.09 | 0.00 | 0.00 | 0.00 | |
Avg Dividend yield | % | 0 | 0.2 | 0 | 0 | 0 | |
Book value per share (Unadj.) | Rs | 33.3 | 36.0 | 38.5 | 41.3 | 43.9 | |
Adj. book value per share | Rs | 30.7 | 33.2 | 35.5 | 38.0 | 43.9 | |
Shares outstanding (eoy) | m | 23.38 | 23.38 | 23.38 | 23.38 | 25.38 | |
Price / Sales ratio | x | 0.6 | 0.3 | 0.2 | 0.2 | 0.2 | |
Avg P/E ratio | x | 35.6 | 16.1 | 8.4 | 9.9 | 16.8 | |
P/CF ratio (eoy) | x | 31.9 | 14.0 | 7.3 | 8.7 | 12.9 | |
Price / Book Value ratio | x | 2.8 | 1.3 | 0.5 | 0.7 | 1.0 | |
Dividend payout | % | 0 | 3.6 | 0 | 0 | 0 | |
Avg Mkt Cap | Rs m | 2,198 | 1,053 | 486 | 644 | 1,099 | |
Total wages/salary | Rs m | 4 | 4 | 3 | 2 | 7 |
AAREY DRUGS INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 3,479 | 3,547 | 3,001 | 3,484 | 4,927 | |
Other income | Rs m | 32 | 43 | 67 | 70 | 27 | |
Total revenues | Rs m | 3,511 | 3,590 | 3,068 | 3,554 | 4,954 | |
Gross profit | Rs m | 76 | 79 | 32 | 47 | 113 | |
Depreciation | Rs m | 7 | 10 | 9 | 9 | 20 | |
Interest | Rs m | 19 | 22 | 18 | 24 | 20 | |
Profit before tax | Rs m | 82 | 90 | 72 | 83 | 100 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | 20 | 24 | 14 | 18 | 35 | |
Profit after tax | Rs m | 62 | 65 | 58 | 65 | 65 | |
Gross profit margin | % | 2.2 | 2.2 | 1.1 | 1.3 | 2.3 | |
Effective tax rate | % | 24.6 | 27.2 | 20.0 | 21.5 | 34.7 | |
Net profit margin | % | 1.8 | 1.8 | 1.9 | 1.9 | 1.3 |
AAREY DRUGS BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 1,573 | 1,330 | 1,813 | 2,184 | 2,263 | |
Current liabilities | Rs m | 882 | 576 | 1,003 | 1,308 | 1,301 | |
Net working cap to sales | % | 19.9 | 21.2 | 27.0 | 25.1 | 19.5 | |
Current ratio | x | 1.8 | 2.3 | 1.8 | 1.7 | 1.7 | |
Inventory Days | Days | 0 | 0 | 1 | 0 | 3 | |
Debtors Days | Days | 99,975,540 | 108,824,991 | 116,927,466 | 169,723,827 | 100,964,703 | |
Net fixed assets | Rs m | 125 | 127 | 127 | 147 | 188 | |
Share capital | Rs m | 234 | 234 | 234 | 234 | 254 | |
"Free" reserves | Rs m | 545 | 609 | 666 | 732 | 859 | |
Net worth | Rs m | 779 | 842 | 900 | 965 | 1,113 | |
Long term debt | Rs m | 1 | 0 | 0 | 0 | 0 | |
Total assets | Rs m | 1,698 | 1,457 | 1,941 | 2,330 | 2,452 | |
Interest coverage | x | 5.3 | 5.0 | 5.1 | 4.4 | 5.9 | |
Debt to equity ratio | x | 0 | 0 | 0 | 0 | 0 | |
Sales to assets ratio | x | 2.0 | 2.4 | 1.5 | 1.5 | 2.0 | |
Return on assets | % | 4.8 | 6.0 | 3.9 | 3.8 | 3.5 | |
Return on equity | % | 7.9 | 7.8 | 6.4 | 6.7 | 5.9 | |
Return on capital | % | 13.0 | 13.3 | 10.0 | 11.1 | 10.8 | |
Exports to sales | % | 0 | 0 | 0 | 0.1 | 0.2 | |
Imports to sales | % | 0 | 0 | 0 | 0 | 0 | |
Exports (fob) | Rs m | 0 | 0 | 1 | 3 | 9 | |
Imports (cif) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Fx inflow | Rs m | 0 | 0 | 1 | 3 | 9 | |
Fx outflow | Rs m | 0 | 0 | 8 | 18 | 301 | |
Net fx | Rs m | 0 | 0 | -7 | -15 | -292 |
AAREY DRUGS CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | -204 | 7 | 29 | 55 | -45 | |
From Investments | Rs m | -6 | -12 | -9 | -29 | -22 | |
From Financial Activity | Rs m | 233 | -25 | -18 | -25 | 62 | |
Net Cashflow | Rs m | 24 | -30 | 1 | 1 | -5 |
Share Holding
Shareholding as on Dec 2022
|
Company Information
|
CHM: Mihir R Ghatalia | COMP SEC: Preeti Paresh Rathi | YEAR OF INC: 1990 | BSE CODE: 524412 | FV (Rs): 10 | DIV YIELD (%): - |
More Trading Company Fact Sheets: ADANI PORTS & SEZ GOKUL AGRO RESOURCES GOLDIAM INTERNATIONAL GOKALDAS EXPORTS INTELLECT DESIGN
Compare AAREY DRUGS With: ADANI PORTS & SEZ GOKUL AGRO RESOURCES GOLDIAM INTERNATIONAL GOKALDAS EXPORTS INTELLECT DESIGN
After opening the day marginally lower, Indian share markets witnessed a sharp selloff as the session progressed and ended deep in red.